TRINITY BIOTECH PLC
TRIBNasdaqHealthcare · In Vitro & In Vivo Diagnostic Substances · L2 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 20-Fmissed a reporting deadline ↗Apr 30, 2025
- NT 20-Fmissed a reporting deadline ↗May 1, 2023
- NT 20-Fmissed a reporting deadline ↗May 1, 2019
- NT 20-Fmissed a reporting deadline ↗Jul 1, 2003
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Perceptive Advisors LlcActivist (13D)May 4, 2026
- Novus Diagnostics Ltd.Passive (13G)Mar 6, 2026
- Dayli Partners, Inc.Activist (13D)Dec 15, 2025
- Mico Ivd Holdings, LlcActivist (13D)Dec 10, 2025
- New Main Equity Co., Ltd.Activist (13D)Dec 26, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 242,867 | 3.3 | +4.1% |
| Apr 30, 2026 | 233,333 | 3.5 | -42.1% |
| Apr 15, 2026 | 402,865 | 3.0 | +38.3% |
| Mar 31, 2026 | 291,283 | 1.3 | +44.6% |
| Mar 13, 2026 | 201,490 | 1.0 | -18.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.